HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
+9.13%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$2.44B
AUM Growth
+$2.44B
(-9.4%)
Cap. Flow
-$376M
Cap. Flow
% of AUM
-15.43%
Top 10 Holdings %
Top 10 Hldgs %
44.28%
Holding
112
New
29
Increased
17
Reduced
20
Closed
38
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$106M |
| 2 |
CVS Health
CVS
|
$106M |
| 3 |
Bristol-Myers Squibb
BMY
|
$98.5M |
| 4 |
Thermo Fisher Scientific
TMO
|
$92.3M |
| 5 |
Natera
NTRA
|
$89.7M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$111M |
| 2 |
Incyte
INCY
|
$93M |
| 3 |
Agios Pharmaceuticals
AGIO
|
$79.2M |
| 4 |
AbbVie
ABBV
|
$78.9M |
| 5 |
IQVIA
IQV
|
$77.6M |
Sector Composition
| 1 | Healthcare | 90.66% |
| 2 | Consumer Discretionary | 4.55% |
| 3 | Real Estate | 2.63% |
| 4 | Financials | 1.91% |
| 5 | Technology | 0% |
